Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$114K Sell
3,216
-2,908
-47% -$118K ﹤0.01% 1115
2025
Q4
$249K Hold
6,124
0.01% 915
2025
Q3
$288K Buy
6,124
+3,216
+111% +$167K 0.01% 891
2025
Q2
$151K Hold
2,908
﹤0.01% 1018
2025
Q1
$176K Hold
2,908
0.01% 980
2024
Q4
$199K Hold
2,908
0.01% 989
2024
Q3
$209K Hold
2,908
0.01% 950
2024
Q2
$202K Hold
2,908
0.01% 942
2024
Q1
$233K Buy
+2,908
New +$259K 0.01% 912
2023
Q4
Sell
-2,290
Closed -$231K 1250
2023
Q3
$231K Buy
+2,290
New +$263K 0.01% 931
2020
Q2
Sell
-2,350
Closed -$135K 877
2020
Q1
$135K Hold
2,350
0.01% 689
2019
Q4
$263K Buy
+2,350
New +$250K 0.01% 632

Other funds holding CNMD

Vestcor Inc's CNMD Position: Q1 2026 in Review

Vestcor Inc reduced its CONMED (CNMD) stake by 47% in Q1 2026, selling an estimated $118K and leaving 3,216 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #1115.

Vestcor Inc first reported a position in CNMD in Q4 2019 and has held it in 12 quarters since. The position peaked at $288K in Q3 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Vestcor Inc held 3,216 shares of CONMED worth $114K as of Q1 2026.
  • Vestcor Inc sold 2,908 CONMED shares in Q1 2026, an estimated $118K.
  • CONMED made up ﹤0.01% of Vestcor Inc's portfolio in Q1 2026, its #1115 holding.
  • Vestcor Inc first reported a position in CONMED in Q4 2019 and has held it in 12 quarters since.
  • Vestcor Inc's CONMED position peaked at $288K in Q3 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.